Literature DB >> 7994573

The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody.

R L Malby1, W R Tulip, V R Harley, J L McKimm-Breschkin, W G Laver, R G Webster, P M Colman.   

Abstract

BACKGROUND: While it is well known that different antibodies can be produced against a particular antigen, and even against a particular site on an antigen, up until now there have been no structural studies of cross-reacting antibodies of this type. One antibody-antigen complex whose structure is known is that of the influenza virus antigen, neuraminidase, in complex with the NC41 antibody. Another anti-neuraminidase antibody, NC10, binds to an overlapping site on the antigen. The structure of the complex formed by this antibody with neuraminidase is described here and compared with the NC41-containing complex.
RESULTS: The crystal structure of the NC10 Fab-neuraminidase complex has been refined to a nominal resolution of 2.5A. Approximately 80% of the binding site of the NC10 antibody on neuraminidase overlaps with that of the NC41 antibody. The epitope residues of neuraminidase are often engaged in quite different interactions with the two antibodies. Although the NC10 and NC41 antibodies have identical amino acid sequences within the first complementarity determining region of their heavy chains, this is not the basis of the cross-reaction.
CONCLUSIONS: The capacity of two different proteins to bind to the same target structure on a third protein need not be based on the existence of identical or homologous amino acid sequences within those proteins. As we have demonstrated, amino acid residues on the common target structure may be in quite different chemical environments, and may also adopt different conformations within two protein-protein complexes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7994573     DOI: 10.1016/s0969-2126(00)00074-5

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  36 in total

1.  Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

Authors:  Upma Gulati; Chi-Ching Hwang; Lalitha Venkatramani; Shelly Gulati; Stephen J Stray; Janis T Lee; W Graeme Laver; Alexey Bochkarev; Adam Zlotnick; Gillian M Air
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Flexible ligand docking using conformational ensembles.

Authors:  D M Lorber; B K Shoichet
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

3.  Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.

Authors:  Maryna C Eichelberger; Arnold S Monto
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

4.  Crystal structures of a quorum-quenching antibody.

Authors:  Erik W Debler; Gunnar F Kaufmann; Robert N Kirchdoerfer; Jenny M Mee; Kim D Janda; Ian A Wilson
Journal:  J Mol Biol       Date:  2007-03-06       Impact factor: 5.469

Review 5.  Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus.

Authors:  Zhu Guo; Jason R Wilson; Ian A York; James Stevens
Journal:  J Immunol Methods       Date:  2018-07-24       Impact factor: 2.303

6.  Antigenic Determinants of Der p 1: Specificity and Cross-Reactivity Associated with IgE Antibody Recognition.

Authors:  Jill Glesner; Lisa D Vailes; Caleb Schlachter; Nicholas Mank; Wladek Minor; Tomasz Osinski; Maksymilian Chruszcz; Martin D Chapman; Anna Pomés
Journal:  J Immunol       Date:  2016-12-30       Impact factor: 5.422

7.  Evolutionary dynamics of N-glycosylation sites of influenza virus hemagglutinin.

Authors:  Joshua L Cherry; David J Lipman; Anastasia Nikolskaya; Yuri I Wolf
Journal:  PLoS Curr       Date:  2009-08-18

Review 8.  Interactions of protein antigens with antibodies.

Authors:  D R Davies; G H Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

Review 9.  Influenza virus neuraminidase: structure, antibodies, and inhibitors.

Authors:  P M Colman
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

10.  Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites.

Authors:  Sebastian Maurer-Stroh; Jianmin Ma; Raphael Tze Chuen Lee; Fernanda L Sirota; Frank Eisenhaber
Journal:  Biol Direct       Date:  2009-05-20       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.